Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis
Eric B. Suhler, Glenn J. Jaffe, Éric Fortin, Lyndell L. Lim, Pauline T. Merrill, Andrew D. Dick, Antoine P. Brézin, Quan Dong Nguyen, Jennifer E. Thorne, Joachim Van Calster, Luca Cimino, Alfredo Adán, Hiroshi Gotô, Toshikatsu Kaburaki, Michal Kramer, Albert T. Vitale, Martina Kron, Alexandra Song, Jianzhong Liu, Sophia Pathai, Kevin M. Douglas, Ariel Schlaen, Cristina Muccioli, Mirjam E. J. van Velthoven, Manfred Zierhut, James T. Rosenbaum
Topics & Concepts
MedicineAdalimumabUveitisVisual acuityPlaceboAdverse effectIntermediate uveitisMacular edemaOphthalmologyCorticosteroidSurgeryInternal medicineAnterior uveitisPathologyTumor necrosis factor alphaAlternative medicineOcular Diseases and Behçet’s SyndromeCNS Lymphoma Diagnosis and TreatmentSarcoidosis and Beryllium Toxicity Research